Free Trial

Rhumbline Advisers Increases Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Axon Enterprise logo with Industrial Products background

Rhumbline Advisers boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 1.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 150,700 shares of the biotechnology company's stock after acquiring an additional 2,292 shares during the quarter. Rhumbline Advisers owned 0.20% of Axon Enterprise worth $44,342,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. CIBC Asset Management Inc raised its holdings in shares of Axon Enterprise by 0.8% during the second quarter. CIBC Asset Management Inc now owns 9,683 shares of the biotechnology company's stock valued at $2,849,000 after acquiring an additional 79 shares during the last quarter. Natixis Advisors LLC increased its position in shares of Axon Enterprise by 12.6% during the second quarter. Natixis Advisors LLC now owns 28,840 shares of the biotechnology company's stock worth $8,486,000 after purchasing an additional 3,229 shares in the last quarter. GraniteShares Advisors LLC raised its stake in Axon Enterprise by 22.4% in the 2nd quarter. GraniteShares Advisors LLC now owns 2,325 shares of the biotechnology company's stock valued at $684,000 after purchasing an additional 426 shares during the last quarter. D.A. Davidson & CO. lifted its holdings in Axon Enterprise by 2.2% in the 2nd quarter. D.A. Davidson & CO. now owns 12,578 shares of the biotechnology company's stock valued at $3,701,000 after purchasing an additional 273 shares in the last quarter. Finally, Interchange Capital Partners LLC acquired a new stake in Axon Enterprise during the 2nd quarter worth $366,000. Hedge funds and other institutional investors own 79.08% of the company's stock.


Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total value of $167,863.50. Following the sale, the director now directly owns 7,379 shares in the company, valued at $2,752,588.37. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Matthew R. Mcbrady sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the sale, the director now owns 4,892 shares in the company, valued at $1,783,916.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the sale, the director now directly owns 7,379 shares of the company's stock, valued at $2,752,588.37. The disclosure for this sale can be found here. Over the last quarter, insiders sold 277,750 shares of company stock valued at $101,046,568. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 0.1 %

Shares of NASDAQ:AXON traded down $0.24 during mid-day trading on Friday, reaching $354.62. 497,943 shares of the company were exchanged, compared to its average volume of 518,284. The firm has a market cap of $26.76 billion, a price-to-earnings ratio of 102.36, a P/E/G ratio of 9.78 and a beta of 0.95. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. Axon Enterprise, Inc. has a 1 year low of $189.12 and a 1 year high of $378.89. The firm's 50-day simple moving average is $330.20 and its 200 day simple moving average is $310.26.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million during the quarter, compared to analysts' expectations of $478.35 million. During the same period in the previous year, the firm posted $0.80 earnings per share. The company's revenue was up 34.5% on a year-over-year basis. Equities research analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AXON. Bank of America began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a "buy" rating and a $380.00 price target on the stock. Needham & Company LLC reissued a "buy" rating and issued a $400.00 target price on shares of Axon Enterprise in a research note on Wednesday, August 7th. Northland Securities upped their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a research report on Thursday, August 8th. Craig Hallum increased their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a report on Wednesday, August 7th. Finally, Jefferies Financial Group began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a "buy" rating and a $385.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $358.08.

Check Out Our Latest Stock Analysis on AXON

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should you invest $1,000 in Axon Enterprise right now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines